Immunoassay for Colistin Monitoring in Critically Ill Patients Receiving Colistin Methanesulfonate Therapy

<b>Background/Objectives</b>: Colistin (COL), administered as a prodrug colistimethate sodium (CMS), is commonly used to treat infections caused by multidrug-resistant Gram-negative bacteria in critically ill patients. Given high CMS instability, very complex and variable pharmacokinetics (PK) and h...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yury A. Surovoy, Inna A. Galvidis, Akmal I. Alimov, Zhanhui Wang, Artem O. Melekhin, Maksim A. Burkin
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2026-06-01
Edice:	Pharmaceuticals
Témata:	colistin polymyxins therapeutic drug monitoring ELISA pharmacokinetics
On-line přístup:	https://www.mdpi.com/1424-8247/19/6/880
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!